Farther Finance Advisors’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
HWAM
LSERS
SOADOR
LTAS
ORI
SAM
BC
YCM
Farther Finance Advisors's CORT Position: Q2 2026 in Review
Farther Finance Advisors increased its Corcept Therapeutics (CORT) stake by 181% in Q2 2026, buying an estimated $39.1K and bringing the position to 1,007 shares worth $87.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2808.
Farther Finance Advisors first reported a position in CORT in Q4 2022 and has held it in 15 quarters since. The position peaked at $89.4K in Q2 2024. 61 funds tracked by Wall St. Rank hold CORT as of Q2 2026.
- Farther Finance Advisors held 1,007 shares of Corcept Therapeutics worth $87.7K as of Q2 2026.
- Farther Finance Advisors bought 648 Corcept Therapeutics shares in Q2 2026, an estimated $39.1K.
- Corcept Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #2808 holding.
- Farther Finance Advisors first reported a position in Corcept Therapeutics in Q4 2022 and has held it in 15 quarters since.
- Farther Finance Advisors's Corcept Therapeutics position peaked at $89.4K in Q2 2024.
- 61 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.
Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.